Quick Takeaways
- Leviticus Partners LP filed SCHEDULE 13G for HARVARD BIOSCIENCE INC Common Stock (HBIO).
- Disclosed ownership: 7.5%.
- Date of event: 14 Mar 2025.
Leviticus Partners LP - 14 Mar 2025 SCHEDULE 13G Report for HARVARD BIOSCIENCE INC Common Stock (HBIO)
- Filing Manager
- Leviticus Partners LP
- Reporting Manager
- Leviticus Partners LP
- Security
- HARVARD BIOSCIENCE INC Common Stock
- Symbol
- HBIO
- Shares outstanding
- 43,793,800 shares
- Disclosed Ownership
- 3,284,535 shares
- Ownership
- 7.5%
- Form type
- SCHEDULE 13G
- Filing time
- 17 Mar 2025, 10:33:36 UTC
- Date of event
- 14 Mar 2025
- Previous filing
- 04 Feb 2025
- Next filing
- 08 Apr 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"Leviticus Partners LP disclosed 7.5% ownership in HARVARD BIOSCIENCE INC Common Stock (HBIO) on 14 Mar 2025."
What Changed
- Previous schedule filing date: 04 Feb 2025.
- Current filing was accepted on 17 Mar 2025, 10:33.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Source Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting Managers (2)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Leviticus Partners LP | 7.5% | 3,284,535 | 3,181,143 | 0 | Adam M Hutt | Managing Member | |
| AMH Equity LLC | 7.5% | 3,284,535 | 103,392 | 0 | Adam M Hutt | Managing Member |